Sartar Therapeutics is a Finnish drug development company focused on developing treatments for soft tissue sarcomas. Sartar utilizes principles of precision medicine, drug repurposing and reformulation to provide efficacious cancer therapies to unmet clinical needs. Our first product, currently in preclinical phase, is targeting gastrointestinal stromal tumour (GIST).

We are now looking for

Drug Development Director

to support our preclinical development program towards clinical trials.

The ideal candidate for this position is an enthusiastic professional with a strong background in pharmaceutical industry and drug development. Experience in preclinical studies, pharmaceutical development, clinical trials, regulatory affairs and/or project leadership and CRO management is appreciated, to ensure the professional conduct of various activities related to our preclinical and subsequent clinical development program. You will interface with external collaborators and contract research organisations internationally.

We offer a highly motivating position in a startup environment with a variety of tasks where you can take responsibility and grow professionally. You will become a member of a small multi-disciplinary team developing new treatments for unmet clinical needs. Appreciation of your colleagues and flexible startup attitude are integral part of working at Sartar.

For more information please contact Katja Ivanitskiy, CEO, +358 400 802838. Please send your application at your earliest convenience, with salary request and CV, to Katja Ivanitskiy by 2nd May 2021. The position is filled as soon as a suitable candidate is found.